Ligand Pharmaceuticals Inc (LGND)

Net Debt

$124.75M

Quarterly · Period ending: · USD

LGND logo

LGND Net Debt

Latest reported$124.75M
LGND Quarterly Net Debt ($1.40M → $124.75M)
High-resolution chart · PNG

LGND net debt history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Ligand Pharmaceuticals Inc Net Debt — Quarterly (USD)
Period endingNet Debt (USD)
124,751,000
336,900,000
276,564,000
311,621,000
-61,927,000
-43,541,000
-65,202,000
-56,262,000
-10,556,000
-43,899,000
-16,789,000
-12,946,000
-16,774,000
-52,000
42,740,000
109,770,000
139,333,000
180,207,000
304,864,000
307,152,000
300,546,000
334,151,000
408,795,000
3,006,000
345,425,000
337,619,000
578,641,000
-457,294,000
-669,275,000
-779,438,000
-82,084,000
700,423,000
-150,645,000
176,523,000
22,868,000
188,818,000
46,003,000
205,107,000
71,862,000
86,000,000
146,013,000
91,452,000
5,153,000
109,181,000
18,958,000
32,801,000
28,906,000
7,380,000
-19,329,000
-7,208,000
-6,870,000
9,104,000
9,647,000
13,669,000
15,897,000
30,623,000
45,797,000
30,470,000
23,245,000
65,766,000
36,534,000
34,844,000
19,505,000
39,894,000
45,753,000
34,871,000
20,333,000
52,311,000
54,381,000
53,486,000
-24,746,000
-10,913,000
-27,933,000
-57,902,000
-74,657,000
-66,602,000
-100,363,000
-400,119,000
-118,495,000
132,404,000
103,201,000
96,644,000
106,164,000
123,432,000
141,218,000
123,135,000
81,706,000
128,169,000
128,092,000
108,030,000
113,501,000
82,248,000
140,421,000
144,376,000
114,914,000
-7,218,000
-17,355,000
37,819,000
121,384,000
121,857,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.